Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional pentoxifylline for alopecia areata evaluated by dermoscopy
PACTR202509732842066Phase 4Completed
- Sponsor
- Al-Azhar University Hospitals
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pentoxifylline in alopecia areata, sponsored by Al-Azhar University Hospitals. Primary endpoints: Change in Severity of Alopecia Tool score and Dermoscopic evaluation of regrowth. Started Sep 2023; status: completed.
02
Drugs
pentoxifylline
03
Conditions
alopecia areata
Beyond the preview
Go deeper on PACTR202509732842066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202509732842066.